Skip to main content
. 2023 Feb 28;14:1081741. doi: 10.3389/fendo.2023.1081741

Table 2.

meta-analysis of SNV-eGFRcreatinine summary data in diabetes mellitus and its subtypes (model 1).

Genetic variant
(EA)
Diabetes type N Effect
(Beta [95% CI])
PHET P-value
rs144360241 (C) T1D 2,177 -0.14 [-0.32; 0.05] 0.38 0.15
T2D 30,727 0.01 [-0.01; 0.04] 0.62 0.40
Combined DM 32,904 0.01 [-0.02; 0.04] 0.42 0.53
rs45551835 (A) T1D 3,236 -0.02 [-0.13; 0.08] 0.34 0.69
T2D 30,814 0.01 [0.00; 0.03] 0.08 0.09
Combined DM 34,050 0.01 [0.00; 0.02] 0.15 0.10
rs141640975 (A) T1D 2,177 0.16 [-0.11; 0.44] 0.75 0.25
T2D 30,816 0.00 [-0.03; 0.03] 0.53 0.83
Combined DM 32,993 0.01 [-0.02; 0.03] 0.60 0.73
rs1801239 (C) T1D 3,236 -0.01 [-0.06; 0.03] 0.20 0.57
T2D 30,834 0.00 [0.00; 0.01] 0.21 0.64
Combined DM 34,070 0.00 [0.00; 0.01] 0.23 0.59

SNV, single nucleotide variant; eGFRcreatinine, log-transformed estimated glomerular filtration rate based on the CKD-EPI2012 equation; EA, effect allele (i.e., minor allele); N, sample size; Beta, Beta coefficient; CI, confidence interval; PHet, P-value for heterogeneity across studies. PHet< 0.05 indicates variation; T1D: Type 1 diabetes; T2D: Type 2 diabetes; Combined DM: T1D and T2D combined.